Introduction Pharma tenders have evolved; they’re not just about the lowest price anymore. Hospitals, governmen...
Introduction Injectable manufacturing is a high-risk decision for companies to outsource to suppliers in the pharmace...
Introduction The private label (OEM/ODM) model for nutraceutical manufacturing allows companies to quickly introduce...
Introduction As pharmaceutical companies expand into multiple markets and face ever-growing complexities in their reg...
Introduction Worldwide compliance for pharmaceutical supply chains continues to grow and change, as a result the cont...
Introduction Asia's nutraceutical and dietary supplement industry is experiencing tremendous growth. This growth...
Introduction In 2026, API pricing for global buyers will no longer be based only on manufacturing costs. Factors such...
Introduction Latin America is continuously evolving and growing in the field of pharmaceuticals. Due to the increasin...
Introduction In the year 2026, global sourcing of active pharmaceutical ingredients (APIs) has transformed into a hig...
Named-Patient Import Programs: A Global Guide for Hospitals & Procurement Teams (2026) Around the world, a large...
The complexities of global pharmaceutical sourcing have never been greater. By 2026, buyers are likely to face an increa...
Quick intro Global pharma buyers generally source their generic APIs from India and China due to their vast productio...
Stay updated on pharma trends and marketplace opportunities.